Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-25-012492
Filing Date
2025-08-20
Accepted
2025-08-20 17:20:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8090
  Complete submission text file 0001214659-25-012492.txt   9756
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Subject) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87811 | Film No.: 251237763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062
Business Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062 5148398866
1Globe Capital LLC (Filed by) CIK: 0001562189 (see all company filings)

EIN.: 800841812 | Fiscal Year End: 1231
Type: SCHEDULE 13G